Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Artes Biotechnology
Artes Biotechnology
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Media
Offering packet solutions for biopharmaceutical processes
Artes Biotechnology, and Minapharm Pharmaceuticals and Chemical Industries have made a business alliance to out-license their respective biopharmaceutical technologies
Research & Development
ARTES and BioSun announce codevelopment for HPV vaccine
ARTES Biotechnology and BioSun Pharmed are tojoin forces to develop and manufacture an HPV (human papilloma virus) vaccine in Iran
Research & Development
Artes Biotechnology and Burnet Institute join forces to develop novel hepatitis C vaccine
The project will combine Burnet's HepSeeVaxDelta3 technology with Artes’ Metavax technology
Research & Development
ARTES and Burnet join forces to develop anti-malaria vaccine
Transmission-blocking vaccines could play a significant role in the eventual eradication of malaria
Manufacturing
ARTES Biotechnology to collaborate with Bio Farma on vaccine development
First agreement for VLP-based vaccine technology transfer signed on 1 July in Bandung
Research & Development
Artes acquires Anavax VLP technology
Will develop processes for specific vaccines
Subscribe now